The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Role of pazopanib (PZ) in modulating hormone resistance in advanced breast cancer (ABC).
 
Melanie Catherine Majure
No Relationships to Disclose
 
Michelle E. Melisko
Stock and Other Ownership Interests - Merrimack (I)
Consulting or Advisory Role - Merrimack (I)
Speakers' Bureau - Agendia; Genetic Technologies (I)
Research Funding - Celldex; Galena Biopharma; Genentech
Patents, Royalties, Other Intellectual Property - University of California, San Francisco (I)
 
Ariel R. Karwat
No Relationships to Disclose
 
Amy Jo Chien
Research Funding - Merck; Puma Biotechnology
 
Andrei Goga
No Relationships to Disclose
 
Mark M. Moasser
No Relationships to Disclose
 
John W. Park
Stock and Other Ownership Interests - Merrimack
Consulting or Advisory Role - Merrimack
Speakers' Bureau - Agendia (I); Genentech
Research Funding - Celldex (I); Galena Biopharma (I); Genentech (I)
Patents, Royalties, Other Intellectual Property - University of California, San Francisco
 
Amy N. DeLuca
No Relationships to Disclose
 
Hope S. Rugo
Honoraria - Genomic Health
Speakers' Bureau - Genomic Health
Research Funding - Celsion (Inst); Celsion (Inst); Eisai (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Nektar (Inst); Novartis (Inst); OBI Pharma (Inst); Pfizer (Inst); Plexxikon (Inst)
Travel, Accommodations, Expenses - Mylan; Nektar; Novartis; OBI Pharma; Roche/Genentech